CERT vs IDXX · rev $187.4M vs P/E 40, rev $2.36B
Certara Inc (CERT) versus IDEXX Laboratories Inc (IDXX) — a side-by-side from cached financials, not a winner call.
Certara Inc (CERT) is a health information services company listed on US.
IDEXX Laboratories Inc (IDXX) is a diagnostics & research company listed on NASDAQ.
Latest reported CERT revenue for 2026-06-30 was $187.4M. Net income was -$64.0M. Revenue was up 75.2% from 2026-03-31 to 2026-06-30. CERT currently screens at market cap $1.86B.
Latest reported IDXX revenue for 2026-06-30 was $2.36B. Net income was $616.9M. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
CERT currently screens at market cap $1.86B. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
Not investment advice. Open the CERT and IDXX stock pages for the full models.
Not investment advice.